Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY-NC-NDBMC public health

Estimated COVID-19 outcomes averted by primary vaccine series among King County, Washington residents, February - September 2021: a retrospective modelling study of surveillance data.

6 affiliations
  1. 1Public Health - Seattle & King County, Seattle, Washington, USA. [email protected].
  2. 2Public Health - Seattle & King County, Seattle, Washington, USA. [email protected].
  3. 3Public Health - Seattle & King County, Seattle, Washington, USA.
  4. 4Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  5. 5Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  6. 6Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Abstract

Background

The initial monovalent coronavirus disease 2019 (COVID-19) vaccines were highly effective against severe COVID-19 outcomes. Robust estimates of the number of adverse health outcomes averted by the first phase of vaccination show the potential population-level impact of vaccine uptake and can inform future policy and planning decisions. In this modelling study, we estimate the number of COVID-19 hospitalizations and deaths in King County, Washington averted by primary series vaccination across the first eight months of uptake (February 2021 - September 2021).Methods

This study used surveillance data on hospitalizations and deaths due to COVID-19 from February 2021 through September 2021 for all King County residents 12 years and older. Data were reported routinely to the Washington State Department of Health. Outcomes were manually reviewed by Public Health-Seattle & King County and incidental hospitalizations and deaths were excluded, resulting in robust identification of outcomes due to COVID-19. We estimated outcomes averted by calculating the rate difference between vaccinated and unvaccinated groups for COVID-19 hospitalizations and deaths, and then applying the rate difference to the number of vaccinated individuals susceptible to COVID-19. Results were calculated by day and age group, then aggregated across the full study period for total counts.Results

There were 3,086 recorded COVID-19 hospitalizations and 591 COVID-19 deaths among King County residents ages 12 years and older during the study period. In this modelling framework, we estimate 16,607 COVID-19 hospitalizations and 4,307 deaths averted by vaccination during the same period. In the absence of vaccination, the number of COVID-19 hospitalizations would have been over six times greater than was observed, and the number of COVID-19 deaths nearly eight times greater.Conclusions

This study estimates that primary COVID-19 vaccination had a substantial impact on COVID-19 outcomes at the population level in King County, Washington. The validity of our estimates is uniquely strengthened by a rigorous definition of hospitalizations due to COVID-19. Local health jurisdictions can utilize these methods to illustrate the impact of vaccination efforts and inform resource allocation at the local level.

Related

  1. Notes from the Field: Use of Enhanced Surveillance to Detect Severe Group A Streptococcus Infections Among Persons Experiencing Homelessness — Missoula County, Montana, July 2024–September 2025
    Beth Hopkins, Ashley A Meehan, Stephen G Mugel +16
    MMWR. Morbidity and mortality weekly reportPeer-reviewedCC0Full textEpidemiology & public healthEurope PMCEurope PMCPMC
  2. Minimised SARS-CoV-2 transmission during Tokyo 2020 Olympic and Paralympic Games: insights from enhanced integrated surveillance, Japan, July to September 2021.
    Munehisa Fukusumi, Keiko Tsukada, Kanako Otani +10
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ
  3. Occlusal Vertical Dimension Estimated from 3-Dimensional Facial Scans Using a Craniometric Equation: A Retrospective Clinical Study
    Louise Viel, Virginie Chuy, Justine Bouscasse +2
    The Journal of Prosthetic DentistryPeer-reviewedCC BY 4.0Full textGeneral biologyEpidemiology & public healthHAL
  4. Low PHASES-Estimated Rupture Risk Among Patients Presenting with Ruptured Intracranial Aneurysms: A Retrospective Single-Centre Observational Study
    Mateusz Krakowiak, Bartłomiej Kulesza, Cezary Grochowski +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  5. Association and Incremental Discriminative Value of Four Estimated Muscle-Related Indices for Progression from Prediabetes to Type 2 Diabetes Mellitus: A Retrospective Cohort Study with up to 10 Years of Follow-Up
    Xinrui Cao, Yan He, Zhihao Ni +3
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
BibTeX
@article{lau2026estimated,
  title = {{Estimated COVID-19 outcomes averted by primary vaccine series among King County, Washington residents, February - September 2021: a retrospective modelling study of surveillance data.}},
  author = {Kathryn M Lau and Katrin E Fabian and Meaghan S Fagalde and Libby C Page and Sargis Pogosjans and Eric J Chow},
  journal = {BMC public health},
  year = {2026},
  month = aug,
  doi = {10.1186/s12889-026-28801-3},
  url = {https://europepmc.org/article/MED/42968025},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Estimated COVID-19 outcomes averted by primary vaccine series among King County, Washington residents, February - September 2021: a retrospective modelling study of surveillance data.
AU  - Kathryn M Lau
AU  - Katrin E Fabian
AU  - Meaghan S Fagalde
AU  - Libby C Page
AU  - Sargis Pogosjans
AU  - Eric J Chow
PY  - 2026
DA  - 2026/08/05
JO  - BMC public health
DO  - 10.1186/s12889-026-28801-3
UR  - https://europepmc.org/article/MED/42968025
AB  - Background  The initial monovalent coronavirus disease 2019 (COVID-19) vaccines were highly effective against severe COVID-19 outcomes. Robust estimates of the number of adverse health outcomes averted by the first phase of vaccination show the potential population-level impact of vaccine uptake and can inform future policy and planning decisions. In this modelling study, we estimate the number of COVID-19 hospitalizations and deaths in King County, Washington averted by primary series vaccination across the first eight months of uptake (February 2021 - September 2021).Methods  This study used surveillance data on hospitalizations and deaths due to COVID-19 from February 2021 through September 2021 for all King County residents 12 years and older. Data were reported routinely to the Washington State Department of Health. Outcomes were manually reviewed by Public Health-Seattle & King County and incidental hospitalizations and deaths were excluded, resulting in robust identification of outcomes due to COVID-19. We estimated outcomes averted by calculating the rate difference between vaccinated and unvaccinated groups for COVID-19 hospitalizations and deaths, and then applying the rate difference to the number of vaccinated individuals susceptible to COVID-19. Results were calculated by day and age group, then aggregated across the full study period for total counts.Results  There were 3,086 recorded COVID-19 hospitalizations and 591 COVID-19 deaths among King County residents ages 12 years and older during the study period. In this modelling framework, we estimate 16,607 COVID-19 hospitalizations and 4,307 deaths averted by vaccination during the same period. In the absence of vaccination, the number of COVID-19 hospitalizations would have been over six times greater than was observed, and the number of COVID-19 deaths nearly eight times greater.Conclusions  This study estimates that primary COVID-19 vaccination had a substantial impact on COVID-19 outcomes at the population level in King County, Washington. The validity of our estimates is uniquely strengthened by a rigorous definition of hospitalizations due to COVID-19. Local health jurisdictions can utilize these methods to illustrate the impact of vaccination efforts and inform resource allocation at the local level.
SN  - 1471-2458
ER  -